1,721,007 research outputs found
sj-docx-1-msj-10.1177_13524585231199084 – Supplemental material for Vaccination frequency in people newly diagnosed with multiple sclerosis
No full textSupplemental material, sj-docx-1-msj-10.1177_13524585231199084 for Vaccination frequency in people newly diagnosed with multiple sclerosis by Sonia Darvishi, Ewan Donnachie, Christiane Gasperi, Alexander Hapfelmeier and Bernhard Hemmer in Multiple Sclerosis Journal</p
Supplemental material for Serum heat shock protein 70 levels as a biomarker for inflammatory processes in multiple sclerosis
No full textSupplemental material for Serum heat shock protein 70 levels as a biomarker for inflammatory processes in multiple sclerosis by Patricia Lechner, Dorothea Buck, Lisa Sick, Bernhard Hemmer and Gabriele Multhoff in Multiple Sclerosis Journal – Experimental, Translational and Clinical</p
sj-tiff-2-msj-10.1177_13524585231199084 – Supplemental material for Vaccination frequency in people newly diagnosed with multiple sclerosis
No full textSupplemental material, sj-tiff-2-msj-10.1177_13524585231199084 for Vaccination frequency in people newly diagnosed with multiple sclerosis by Sonia Darvishi, Ewan Donnachie, Christiane Gasperi, Alexander Hapfelmeier and Bernhard Hemmer in Multiple Sclerosis Journal</p
sj-docx-1-msj-10.1177_13524585221080542 – Supplemental material for Association of pregnancies with risk of multiple sclerosis
No full textSupplemental material, sj-docx-1-msj-10.1177_13524585221080542 for Association of pregnancies with risk of multiple sclerosis by Christiane Gasperi, Alexander Hapfelmeier, Antonius Schneider, Klaus A Kuhn, Ewan Donnachie and Bernhard Hemmer in Multiple Sclerosis Journal</p
sj-docx-2-tan-10.1177_17562864231162661 – Supplemental material for The impact of disease-modifying therapies on immunoglobulin blood levels in patients with multiple sclerosis: a retrospective cross-sectional study
No full textSupplemental material, sj-docx-2-tan-10.1177_17562864231162661 for The impact of disease-modifying therapies on immunoglobulin blood levels in patients with multiple sclerosis: a retrospective cross-sectional study by Ana Klein, Martina Flaskamp, Achim Berthele, Friederike Held, Harisa Muratovic and Bernhard Hemmer in Therapeutic Advances in Neurological Disorders</p
sj-jpg-1-tan-10.1177_17562864231162661 – Supplemental material for The impact of disease-modifying therapies on immunoglobulin blood levels in patients with multiple sclerosis: a retrospective cross-sectional study
No full textSupplemental material, sj-jpg-1-tan-10.1177_17562864231162661 for The impact of disease-modifying therapies on immunoglobulin blood levels in patients with multiple sclerosis: a retrospective cross-sectional study by Ana Klein, Martina Flaskamp, Achim Berthele, Friederike Held, Harisa Muratovic and Bernhard Hemmer in Therapeutic Advances in Neurological Disorders</p
MSJ763089_supplement – Supplemental material for Effect of <i>HLA-DRB1</i> alleles and genetic variants on the development of neutralizing antibodies to interferon beta in the BEYOND and BENEFIT trials
No full textSupplemental material, MSJ763089_supplement for Effect of HLA-DRB1 alleles and genetic variants on the development of neutralizing antibodies to interferon beta in the BEYOND and BENEFIT trials by B Hemmer, Dorothea Buck, Mark Mühlau, Till FM Andlauer, Wilmar Igl, Eva-Maria Wicklein, Karl Köchert, Frank Weber, Christoph Pohl, Barry Arnason, Giancarlo Comi, Stuart Cook, Massimo Filippi, Hans-Peter Hartung, Douglas Jeffery, Ludwig Kappos, Frederik Barkhof, Gilles Edan, Mark S Freedman, Xavier Montalbán, Bertram Müller-Myhsok and Bernhard Hemmer in Multiple Sclerosis Journal</p
sj-docx-1-msj-10.1177_13524585231168043 – Supplemental material for ECTRIMS/EAN consensus on vaccination in people with multiple sclerosis: Improving immunization strategies in the era of highly active immunotherapeutic drugs
No full textSupplemental material, sj-docx-1-msj-10.1177_13524585231168043 for ECTRIMS/EAN consensus on vaccination in people with multiple sclerosis: Improving immunization strategies in the era of highly active immunotherapeutic drugs by Susana Otero-Romero, Christine Lebrun-Frrénay, Saúl Reyes, Maria Pia Amato, Magda Campins, Mauricio Farez, Massimo Filippi, Yael Hacohen, Bernhard Hemmer, Rosa Juuti, Melinda Magyari, Celia Oreja-Guevara, Aksel Siva, Sandra Vukusic and Mar Tintoré in Multiple Sclerosis Journal</p
sj-docx-3-msj-10.1177_13524585231168043 – Supplemental material for ECTRIMS/EAN consensus on vaccination in people with multiple sclerosis: Improving immunization strategies in the era of highly active immunotherapeutic drugs
No full textSupplemental material, sj-docx-3-msj-10.1177_13524585231168043 for ECTRIMS/EAN consensus on vaccination in people with multiple sclerosis: Improving immunization strategies in the era of highly active immunotherapeutic drugs by Susana Otero-Romero, Christine Lebrun-Frénay, Saúl Reyes, Maria Pia Amato, Magda Campins, Mauricio Farez, Massimo Filippi, Yael Hacohen, Bernhard Hemmer, Rosa Juuti, Melinda Magyari, Celia Oreja-Guevara, Aksel Siva, Sandra Vukusic and Mar Tintoré in Multiple Sclerosis Journal</p
sj-docx-2-msj-10.1177_13524585231168043 – Supplemental material for ECTRIMS/EAN consensus on vaccination in people with multiple sclerosis: Improving immunization strategies in the era of highly active immunotherapeutic drugs
No full textSupplemental material, sj-docx-2-msj-10.1177_13524585231168043 for ECTRIMS/EAN consensus on vaccination in people with multiple sclerosis: Improving immunization strategies in the era of highly active immunotherapeutic drugs by Susana Otero-Romero, Christine Lebrun-Frrénay, Saúl Reyes, Maria Pia Amato, Magda Campins, Mauricio Farez, Massimo Filippi, Yael Hacohen, Bernhard Hemmer, Rosa Juuti, Melinda Magyari, Celia Oreja-Guevara, Aksel Siva, Sandra Vukusic and Mar Tintoré in Multiple Sclerosis Journal</p
- …
